DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status
Current clinical guidelines suggest that breast cancers with low hormone receptor expression (LowHR) in 1-10% of tumor cells should be regarded as hormone receptor positive. However, clinical data show that these patients have worse outcome compared to patients with hormone receptor expression above...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
03 October 2021
|
| In: |
Clinical epigenetics
Year: 2021, Volume: 13, Pages: 1-10 |
| ISSN: | 1868-7083 |
| DOI: | 10.1186/s13148-021-01176-5 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13148-021-01176-5
|
| Author Notes: | Philipp Jurmeister, Karsten Weber, Sonia Villegas, Thomas Karn, Michael Untch, Anne Thieme, Volkmar Müller, Eliane Taube, Peter Fasching, Wolfgang D. Schmitt, Frederik Marmé, Elmar Stickeler, Bruno V. Sinn, Paul Jank, Christian Schem, Frederick Klauschen, Marion van Mackelenbergh, Carsten Denkert, Sibylle Loibl and David Capper |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 178082923X | ||
| 003 | DE-627 | ||
| 005 | 20220820091618.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211209s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13148-021-01176-5 |2 doi | |
| 035 | |a (DE-627)178082923X | ||
| 035 | |a (DE-599)KXP178082923X | ||
| 035 | |a (OCoLC)1341436047 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jurmeister, Philipp |d 1988- |e VerfasserIn |0 (DE-588)1109765428 |0 (DE-627)864333412 |0 (DE-576)47556538X |4 aut | |
| 245 | 1 | 0 | |a DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status |c Philipp Jurmeister, Karsten Weber, Sonia Villegas, Thomas Karn, Michael Untch, Anne Thieme, Volkmar Müller, Eliane Taube, Peter Fasching, Wolfgang D. Schmitt, Frederik Marmé, Elmar Stickeler, Bruno V. Sinn, Paul Jank, Christian Schem, Frederick Klauschen, Marion van Mackelenbergh, Carsten Denkert, Sibylle Loibl and David Capper |
| 264 | 1 | |c 03 October 2021 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.12.2021 | ||
| 520 | |a Current clinical guidelines suggest that breast cancers with low hormone receptor expression (LowHR) in 1-10% of tumor cells should be regarded as hormone receptor positive. However, clinical data show that these patients have worse outcome compared to patients with hormone receptor expression above 10%. We performed DNA methylation profiling on 23 LowHR breast cancer specimens, including 13 samples with HER2 amplification and compared our results with a reference breast cancer cohort from The Cancer Genome Atlas to clarify the status for this infrequent but important patient subgroup. | ||
| 700 | 1 | |a Weber, Karsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Villegas, Sonia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Karn, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Untch, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thieme, Anne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller, Volkmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Taube, Eliane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fasching, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmitt, Wolfgang D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |e VerfasserIn |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 aut | |
| 700 | 1 | |a Stickeler, Elmar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sinn, Bruno V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jank, Paul |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schem, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klauschen, Frederick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mackelenbergh, Marion Tina van |d 1981- |e VerfasserIn |0 (DE-588)133221520 |0 (DE-627)691253633 |0 (DE-576)299705056 |4 aut | |
| 700 | 1 | |a Denkert, Carsten |d 1969- |e VerfasserIn |0 (DE-588)118129929 |0 (DE-627)079261124 |0 (DE-576)291730604 |4 aut | |
| 700 | 1 | |a Loibl, Sibylle |e VerfasserIn |0 (DE-588)12433024X |0 (DE-627)085790508 |0 (DE-576)294122753 |4 aut | |
| 700 | 1 | |a Capper, David |d 1979- |e VerfasserIn |0 (DE-588)133950751 |0 (DE-627)558829902 |0 (DE-576)300212402 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical epigenetics |d [Erscheinungsort nicht ermittelbar] : BioMed Central, 2010 |g 13(2021), Artikel-ID 184, Seite 1-10 |h Online-Ressource |w (DE-627)626459028 |w (DE-600)2553921-8 |w (DE-576)325002916 |x 1868-7083 |7 nnas |a DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g elocationid:184 |g pages:1-10 |g extent:10 |a DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13148-021-01176-5 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211209 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 133950751 |a Capper, David |m 133950751:Capper, David |p 20 |y j | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 60000 |d 61300 |d 50000 |e 60000PM132561972 |e 61300PM132561972 |e 50000PM132561972 |k 0/60000/ |k 1/60000/61300/ |k 0/50000/ |p 11 | ||
| 999 | |a KXP-PPN178082923X |e 4017812244 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status","title_sort":"DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status"}],"recId":"178082923X","origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"03 October 2021"}],"name":{"displayForm":["Philipp Jurmeister, Karsten Weber, Sonia Villegas, Thomas Karn, Michael Untch, Anne Thieme, Volkmar Müller, Eliane Taube, Peter Fasching, Wolfgang D. Schmitt, Frederik Marmé, Elmar Stickeler, Bruno V. Sinn, Paul Jank, Christian Schem, Frederick Klauschen, Marion van Mackelenbergh, Carsten Denkert, Sibylle Loibl and David Capper"]},"person":[{"family":"Jurmeister","given":"Philipp","display":"Jurmeister, Philipp","role":"aut"},{"family":"Weber","display":"Weber, Karsten","given":"Karsten","role":"aut"},{"display":"Villegas, Sonia","given":"Sonia","family":"Villegas","role":"aut"},{"role":"aut","family":"Karn","display":"Karn, Thomas","given":"Thomas"},{"given":"Michael","display":"Untch, Michael","family":"Untch","role":"aut"},{"role":"aut","display":"Thieme, Anne","given":"Anne","family":"Thieme"},{"family":"Müller","given":"Volkmar","display":"Müller, Volkmar","role":"aut"},{"given":"Eliane","display":"Taube, Eliane","family":"Taube","role":"aut"},{"role":"aut","family":"Fasching","display":"Fasching, Peter","given":"Peter"},{"role":"aut","display":"Schmitt, Wolfgang D.","given":"Wolfgang D.","family":"Schmitt"},{"family":"Marmé","given":"Frederik","display":"Marmé, Frederik","role":"aut"},{"family":"Stickeler","given":"Elmar","display":"Stickeler, Elmar","role":"aut"},{"role":"aut","family":"Sinn","display":"Sinn, Bruno V.","given":"Bruno V."},{"family":"Jank","display":"Jank, Paul","given":"Paul","role":"aut"},{"role":"aut","family":"Schem","display":"Schem, Christian","given":"Christian"},{"role":"aut","family":"Klauschen","display":"Klauschen, Frederick","given":"Frederick"},{"role":"aut","given":"Marion Tina van","display":"Mackelenbergh, Marion Tina van","family":"Mackelenbergh"},{"display":"Denkert, Carsten","given":"Carsten","family":"Denkert","role":"aut"},{"role":"aut","given":"Sibylle","display":"Loibl, Sibylle","family":"Loibl"},{"given":"David","display":"Capper, David","family":"Capper","role":"aut"}],"relHost":[{"pubHistory":["1.2010 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"626459028","disp":"DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification statusClinical epigenetics","note":["Gesehen am 27.05.2020"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1868-7083"],"zdb":["2553921-8"],"eki":["626459028"]},"part":{"text":"13(2021), Artikel-ID 184, Seite 1-10","volume":"13","extent":"10","year":"2021","pages":"1-10"},"title":[{"title":"Clinical epigenetics","title_sort":"Clinical epigenetics"}],"origin":[{"dateIssuedDisp":"2010-","publisher":"BioMed Central ; Springer","publisherPlace":"[Erscheinungsort nicht ermittelbar] ; Berlin ; Heidelberg [u.a.]","dateIssuedKey":"2010"}]}],"note":["Gesehen am 09.12.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["178082923X"],"doi":["10.1186/s13148-021-01176-5"]},"physDesc":[{"extent":"10 S."}]} | ||
| SRT | |a JURMEISTERDNAMETHYLA0320 | ||